首页 › 基金 › SOFTBANK GROUP CORP. › NMRA
SOFTBANK GROUP CORP. 对 NMRA 的持仓历史
NEUMORA THERAPEUTICS INC. · 医疗保健
SOFTBANK GROUP CORP. 在 Q2 2026 的 13F 申报中披露持有 NMRA(NEUMORA THERAPEUTICS INC.)6,090,301 股,市值约 US$10.4M,约占其申报组合的 0.06%,在其申报持仓中市值排名第 24 位。 SOFTBANK GROUP CORP. 最近 12 个申报季度中有 12 个季度披露了 NMRA 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
SOFTBANK GROUP CORP. 对 NMRA 的持仓演变
SOFTBANK GROUP CORP. 于 Q3 2023 首次披露 NMRA 持仓:7,646,916 股(约 US$107.9M)。 该持仓在 Q4 2023 达到峰值 7,646,916 股,市值约 US$130.4M。 在 12 次申报中,SOFTBANK GROUP CORP. 0 次增持、4 次减持、7 次保持不变。 最近一期申报(Q2 2026)显示持股 6,090,301 股、市值约 US$10.4M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 7.65M | $107.90M | 新进 |
| Q4 2023 | 7.65M | $130.38M | 持有 |
| Q1 2024 | 7.65M | $105.15M | 持有 |
| Q2 2024 | 7.65M | $75.17M | 持有 |
| Q3 2024 | 7.55M | $99.69M | 减持 |
| Q4 2024 | 6.54M | $69.34M | 减持 |
| Q1 2025 | 6.54M | $6.54M | 持有 |
| Q2 2025 | 6.54M | $4.80M | 持有 |
| Q3 2025 | 6.54M | $11.90M | 持有 |
| Q4 2025 | 6.43M | $11.51M | 减持 |
| Q1 2026 | 6.09M | $11.88M | 减持 |
| Q2 2026 | 6.09M | $10.35M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 NMRA 与 13F 数据
NMRA(NEUMORA THERAPEUTICS INC.)属于医疗保健行业。我们追踪的基金中还有 22 只申报持有 NMRA,申报仓位最大的包括:MIC Capital Management UK LLP (US$7.6M), WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST (US$5.6M), ICONIQ Capital, LLC (US$4.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 NMRA 的基金
- MIC Capital Management UK LLP 4.46M 股 · $7.58M · Q2 2026
- WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST 3.31M 股 · $5.63M · Q2 2026
- ICONIQ Capital, LLC 2.56M 股 · $4.35M · Q2 2026
- Lunate Capital Ltd 2.12M 股 · $3.61M · Q2 2026
- Boxer Capital Management, LLC 2.00M 股 · $3.40M · Q2 2026
- JOHNSON & JOHNSON 1.85M 股 · $3.14M · Q2 2026
更多关于 SOFTBANK GROUP CORP.
常见问题
How long has SOFTBANK GROUP CORP. held NMRA?
SOFTBANK GROUP CORP. has disclosed NMRA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is SOFTBANK GROUP CORP.'s current position in NMRA?
As of Q2 2026, SOFTBANK GROUP CORP. holds 6.09M shares of NMRA (NEUMORA THERAPEUTICS INC.), valued at $10.35M, representing 0.06% of its reported portfolio and ranking #24.
Has SOFTBANK GROUP CORP. been buying or selling NMRA?
In the latest 13F filing (Q2 2026), SOFTBANK GROUP CORP. held unchanged its position in NMRA. The position peaked in Q4 2023 at 7.65M shares.
Which other funds hold NMRA?
Other major institutional holders of NMRA include MIC Capital Management UK LLP, WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST, ICONIQ Capital, LLC, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.